Clinical Trial Update: Sleep Apnea Treatment With Expiratory Resistance(Provent™) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from Phase 1 and Phase 2 studies of the Provent expiratory resistance device for obstructive sleep apnea; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Provent

Snippet

Sponsor: Johns Hopkins University | Conditions: Sleep Apnea, Obstructive | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-07-08